Tao Jiang

25.9k total citations · 3 hit papers
450 papers, 15.5k citations indexed

About

Tao Jiang is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Tao Jiang has authored 450 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 217 papers in Genetics, 192 papers in Molecular Biology and 162 papers in Cancer Research. Recurrent topics in Tao Jiang's work include Glioma Diagnosis and Treatment (216 papers), MicroRNA in disease regulation (82 papers) and Ferroptosis and cancer prognosis (58 papers). Tao Jiang is often cited by papers focused on Glioma Diagnosis and Treatment (216 papers), MicroRNA in disease regulation (82 papers) and Ferroptosis and cancer prognosis (58 papers). Tao Jiang collaborates with scholars based in China, United States and Hong Kong. Tao Jiang's co-authors include Chuanbao Zhang, Yongzhi Wang, Yinyan Wang, Chunsheng Kang, Zhaoshi Bao, Guanzhang Li, Yongping You, Wei Zhang, Zheng Zhao and Xing Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Circulation.

In The Last Decade

Tao Jiang

430 papers receiving 15.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients

2021 617 citations Zheng Zhao, Kenan Zhang et al. profile →
An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas

2021 159 citations Guanzhang Li, Yiming Li et al. profile →
Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma

2024 92 citations Guanzhang Li, Di Wang et al. Cell Metabolism profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Tao Jiang	8.0k	6.3k	5.3k	2.7k	2.1k	450	15.5k
Christel Herold‐Mende	6.3k 0.8×	3.6k 0.6×	5.6k 1.1×	1.7k 0.6×	4.3k 2.0×	313	14.4k
David Zagzag	7.8k 1.0×	5.3k 0.8×	5.9k 1.1×	1.7k 0.6×	3.4k 1.6×	258	19.3k
Johannes A. Hainfellner	6.0k 0.8×	3.1k 0.5×	7.5k 1.4×	3.1k 1.1×	2.4k 1.2×	297	14.9k
Torsten Pietsch	9.7k 1.2×	3.4k 0.5×	9.9k 1.9×	3.2k 1.2×	2.5k 1.2×	399	19.3k
Johan M. Kros	6.9k 0.9×	4.7k 0.7×	11.6k 2.2×	4.6k 1.7×	2.4k 1.2×	274	19.2k
Karl H. Plate	10.8k 1.4×	6.0k 0.9×	2.6k 0.5×	1.8k 0.7×	3.1k 1.5×	159	17.1k
Nicolas de Tribolet	6.2k 0.8×	3.1k 0.5×	7.0k 1.3×	2.6k 1.0×	3.9k 1.9×	189	16.4k
Craig Horbinski	4.5k 0.6×	2.5k 0.4×	3.7k 0.7×	1.7k 0.6×	1.7k 0.8×	213	10.6k
Ho‐Keung Ng	5.6k 0.7×	2.9k 0.4×	6.4k 1.2×	2.6k 0.9×	1.7k 0.8×	340	16.1k
Howard A. Fine	9.1k 1.1×	4.9k 0.8×	9.6k 1.8×	3.8k 1.4×	5.2k 2.5×	235	21.3k

Countries citing papers authored by Tao Jiang

Since Specialization

Citations

This map shows the geographic impact of Tao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Jiang more than expected).

Fields of papers citing papers by Tao Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Jiang. The network helps show where Tao Jiang may publish in the future.

Co-authorship network of co-authors of Tao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Jiang. A scholar is included among the top collaborators of Tao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Jiang. Tao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ke, Lei Wang, Gan You, et al.. (2025). High‐Density Electroencephalography Detects Spatiotemporal Abnormalities in Brain Networks in Patients With Glioma‐Related Epilepsy. CNS Neuroscience & Therapeutics. 31(4). e70396–e70396. 1 indexed citations

Han, Hyung Joon & Tao Jiang. (2025). Ownership structure dynamics and corporate innovation capacity. Finance research letters. 80. 107422–107422. 1 indexed citations

Li, Guanzhang, Di Wang, You Zhai, et al.. (2024). Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. Cell Metabolism. 36(8). 1696–1710.e10. 92 indexed citations breakdown →

Lai, Xin, Shuangjie Li, Jun Qiu, et al.. (2024). Predictive role of early treatment dynamics of HBV RNA and HBcrAg for HBeAg seroconversion in children with chronic hepatitis B. Journal of Medical Virology. 96(5). e29670–e29670. 1 indexed citations

Pang, Bo, Yun Liu, Tao Jiang, et al.. (2024). Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management. Cancer Letters. 601. 217154–217154. 1 indexed citations

Wang, Xin, Jingyu Zhao, Yanyun Wang, et al.. (2024). Utility, benefits, and risks of newborn genetic screening carrier reports for families. Journal of Global Health. 14. 4044–4044. 1 indexed citations

Liu, Huanhuan, Yi‐Ting Shen, Zheng Huang, et al.. (2024). Electroacupuncture extends the time window of thrombolytic therapy in rats by reducing disruptions of blood–brain barrier and inhibiting GSDMD-mediated pyroptosis. Brain Research. 1845. 149296–149296. 2 indexed citations

Cui, Xiaoteng, Jixing Zhao, Guanzhang Li, et al.. (2023). Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. Cancer Communications. 43(12). 1326–1353. 22 indexed citations

Zhang, Jun, Fan Dai, Tao Jiang, et al.. (2023). GoSTR, a negative modulator of stem trichome formation in cotton. The Plant Journal. 116(2). 389–403. 9 indexed citations

10.

Hu, Jie, Xing Liu, Kenan Zhang, et al.. (2023). Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis. Journal of Neuro-Oncology. 164(2). 461–471. 1 indexed citations

11.

Jiang, Tao, et al.. (2023). Genome-wide identification of peanut IGT family genes and their potential roles in the development of plant architecture. Scientific Reports. 13(1). 20400–20400. 1 indexed citations

12.

Lin, Yuan, Yangqian Jiang, Tao Jiang, et al.. (2023). Association between prenatal exposure to trace elements mixture and visual acuity in infants: A prospective birth cohort study. Chemosphere. 333. 138905–138905. 6 indexed citations

13.

Zhao, Zheng, Kenan Zhang, Zhiyan Sun, et al.. (2022). WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System. Scientific Data. 9(1). 692–692. 10 indexed citations

14.

Wang, Xin, et al.. (2022). Current attitudes and preconceptions on newborn genetic screening in the Chinese reproductive-aged population. Orphanet Journal of Rare Diseases. 17(1). 322–322. 5 indexed citations

15.

Yu, Kai, Yuqiong Hu, Fan Wu, et al.. (2020). Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies. National Science Review. 7(8). 1306–1318. 98 indexed citations

16.

Li, Jiuyi, Yang Xue, Anna Wenger, et al.. (2019). Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array. Clinical Cancer Research. 25(23). 7068–7077. 8 indexed citations

17.

Jiang, Tao, Min Li, Lin Miao, et al.. (2019). Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification. SHILAP Revista de lepidopterología.

18.

Zhang, Chuanbao, Wen Cheng, Xiufang Ren, et al.. (2017). Tumor Purity as an Underlying Key Factor in Glioma. Clinical Cancer Research. 23(20). 6279–6291. 276 indexed citations

19.

Wang, Zheng, Yajing Hao, Chuanbao Zhang, et al.. (2016). The Landscape of Viral Expression Reveals Clinically Relevant Viruses with Potential Capability of Promoting Malignancy in Lower-Grade Glioma. Clinical Cancer Research. 23(9). 2177–2185. 11 indexed citations

20.

Shi, Yu, Cong Chen, Qing Liu, et al.. (2014). Primate-Specific miR-663 Functions as a Tumor Suppressor by Targeting PIK3CD and Predicts the Prognosis of Human Glioblastoma. Clinical Cancer Research. 20(7). 1803–1813. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact